![]() PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2016 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Boston, US HQ | Locations HQ | Locations Cambridge, GB HQ |
Employees | Employees 8127% increase | Employees N/A | Employees 3014% decrease |
Financial | |||
Net income | Net income ($89.7m) (FY, 2025) | Net income (kr10.7m) (FY, 2024) | Net income N/A |

Audientes is a biotechnology company that develops treatments for muscle diseases.
View company
Mogrify is a biotech company advancing cell therapies.
View company